Daily non-political popular news in brief.

Availability may influence cancer treatment decisions

01-08-2007 · EurekAlert!

Utilization of cancer treatments with limited evidence of benefit may depend on the therapy's availability according to a new study. The study reveals that patients with pancreatic cancer were almost twice as likely to receive radiotherapy, for which there is more controversy regarding efficacy, when the treating hospital had radiotherapy available compared to patients who were treated at centers where radiotherapy was not available.

Keywords: availability, influence, cancer, treatment, decisions, decision

« Previous | Next »

Similar news on "Availability may influence cancer treatment decisions":

A drug's brand name skews patient treatment choices
05-21-2007 · EurekAlert!
The brand name of a drug can strongly influence treatment decisions by patients, according to a randomized trial of decision aids by researchers from McMaster University.
Similar news · Read more »
Comparison of patients' access to new and better cancer drugs reveals inequalities between countries
05-09-2007 · EurekAlert!
Patients around the world face stark inequalities in access to cancer treatment, according to a report published in the cancer journal, Annals of Oncology. The report's authors urge decision makers in every country to take action and ensure that everyone has equal access to new cancer drugs when they are needed, wherever they live.
Similar news · Read more »
Women with breast cancer do not get potentially life-saving information, survey reveals
05-24-2007 · EurekAlert!
New published data from a large pan-European survey indicate that the majority of postmenopausal women with early breast cancer taking post-surgical endocrine therapy are not involved in making key decisions about their treatment, nor are they given sufficient information to make informed treatment choices that could affect their long-term outcome.
Similar news · Read more »
Microarray provides 3 genomic guides to breast cancer treatment decisions
09-06-2007 · EurekAlert!
Three genomic tests separately predict the likelihood that a patient's breast cancer will reoccur after surgery without additional treatment, and the cancer's vulnerability to chemotherapy or hormone therapy, researchers at the University of Texas M. D. Anderson Cancer Center report at the first American Society of Clinical Oncology ASCO Breast Cancer Symposium, Sept. 7-8, in San Francisco.
Similar news · Read more »
Influence of drug companies on medical literature
09-24-2007 · EurekAlert!
In this issue: Physician awareness of drug cost: a systematic review; Bladder cancer decision analysis; and How much of the medical literature is shaped behind the scenes by drug companies?
Similar news · Read more »
UCLA study finds prostate cancer treatments impact on quality of life
04-23-2007 · EurekAlert!
A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways. The findings provide invaluable information for men with prostate cancer who are facing vital treatment decisions.
Similar news · Read more »
Temple University Hospital investigates new prophylactic HPV vaccine
01-30-2007 · EurekAlert!
Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia. According to the American Cancer Society, approximately 500,000 women are diagnosed with high-grade cervical dysplasia each year, with roughly 10,000 cases progressing to cervical cancer.The expected widespread availability of two preventive vaccines may lower the incidence of HPV infection and reduce the risk of cervical cancer.
Similar news · Read more »
Temple University Hospital investigates treatment for cervical dysplasia
01-30-2007 · EurekAlert!
Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia. According to the American Cancer Society, approximately 500,000 women are diagnosed with high-grade cervical dysplasia each year, with roughly 10,000 cases progressing to cervical cancer.The expected widespread availability of two preventive vaccines may lower the incidence of HPV infection and reduce the risk of cervical cancer.
Similar news · Read more »
Growth factors given with chemotherapy associated with increased risk of blood diseases
02-06-2007 · EurekAlert!
Women with breast cancer who receive compounds that stimulate white blood cell production to help their bodies better tolerate chemotherapy are at an increased risk of developing a type of leukemia or a condition called myelodysplastic syndrome, according to a new study in the February 7, Journal of the National Cancer Institute. The authors note that the absolute risk of the conditions is very small, but that risk should still be taken into consideration when making treatment decisions.
Similar news · Read more »
Political decisions harming cancer treatment in Europe
09-24-2007 · EurekAlert!
Recent political decisions have had serious consequences for European oncology, professor John Smyth said today at the European Cancer Conference. He said the new European CanCer Organisation would take an active role in engaging with policy-makers to ensure that future legislation did not have a similarly negative impact.
Similar news · Read more »